XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of option activity
            
   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life 
Outstanding at December 31, 2022   336,758    12.54      
Granted   46,000    12.07      
Exercised             
Forfeited   (19,160)   19.21      
Outstanding at September 30, 2023   363,598   $12.13    6.60 Years  
Schedule of options granted
 
  Nine months ended
  September 30, 2023
Expected volatility 90.2% - 94.5%
Expected term 6.5 - 7 Years
Risk-free interest rate 3.55% - 4.47%
Weighted-average FV $9.71
Schedule of restricted stock awards
      Weighted- 
   Nonvested   Average Grant- 
   Shares   Date Fair Value 
Nonvested at December 31, 2022   17,865   $14.11 
Granted   18,375    11.40 
Vested   (23,765)   13.12 
Forfeited   (5,400)   11.40 
Nonvested at September 30, 2023   7,075   $13.84 
Schedule of warrants outstanding
          
   Number of Warrants   Weighted Average Exercise Price 
Outstanding at December 31, 2022   440,204    9.73 
Granted   200,000    17.00 
Exercised   (21,809)   6.30 
Outstanding at September 30, 2023   618,395   $9.76 
Exercisable at September 30, 2023   618,395   $9.76